Skip to main content

EBR Systems Health Care
Healthcare Medical

$0.900 0.010 (1.12%)

High

$0.91

Low

$0.88

Trades

38

Turnover

$119,823

Volume

134,901
30 June 2023 at 2:35pm
Register to track EBR and receive email alerts.
EBR Announcements on Price Chart

Latest Announcements

Headline Date
Security Purchase Plan Opens 30 June 2023 at 9:20am
Cleansing Notice 29 June 2023 at 10:50am
Application for quotation of securities - EBR 28 June 2023 at 10:10am
Proposed issue of securities - EBR 23 June 2023 at 10:15am
Proposed issue of securities - EBR 23 June 2023 at 10:10am
Proposed issue of securities - EBR 23 June 2023 at 10:10am
Capital Raising Presentation 23 June 2023 at 10:10am
EBR Systems announces a A$35m capital raising 23 June 2023 at 10:10am
Trading Halt 22 June 2023 at 9:05am
EBR Unlocks Second Tranche of Growth Capital Facility 6 June 2023 at 8:50am
CEO Investor Presentation 29 May 2023 at 2:10pm
Results of 2023 Annual Meeting of Stockholders 23 May 2023 at 2:25pm
2023 Annual Meeting Presentation of President & CEO 23 May 2023 at 9:05am
CEO Presentation on SOLVE-CRT Pivotal Trial Top-line Data 22 May 2023 at 8:45am
EBR Reports Positive Results for its Pivotal SOLVE-CRT Trial 22 May 2023 at 8:45am
Shareholder and Investor Webinar - SOLVE-CRT Results 19 May 2023 at 8:45am
Appendix 4G Updated 18 May 2023 at 5:20pm
Notice of Annual Meeting of Stockholders and CDI Proxy Form 27 April 2023 at 10:50am
Appendix 4G 27 April 2023 at 10:30am
Corporate Governance Statement 27 April 2023 at 10:20am
Annual Report to Stockholders 27 April 2023 at 9:55am
Investor Presentation 26 April 2023 at 10:50am
Quarterly Activities/Appendix 4C Cash Flow Report 26 April 2023 at 8:50am
Notification of cessation of securities - EBR 18 April 2023 at 3:40pm
Notification regarding unquoted securities - EBR 14 April 2023 at 2:45pm
EBR Systems to Present at Emergence Conference 22 March 2023 at 11:00am
SOLVE-CRT trial data accepted into HRS conference 21 March 2023 at 9:10am
Application for quotation of securities - EBR 20 March 2023 at 11:59am
EBR confirms no anticipated financial exposure to SVB 13 March 2023 at 9:35am
Appendix 3Y 6 March 2023 at 12:30pm
Appendix 3Y 3 March 2023 at 1:35pm
EBR Systems Financial Results for FY2022 28 February 2023 at 9:20am
Appendix 4E and FY2022 Consolidated Financial Statements 28 February 2023 at 9:20am
Appointment of consulting Chief Scientific Officer 22 February 2023 at 9:35am
Application for quotation of securities - EBR 16 February 2023 at 3:30pm
Annual Meeting of Stockholders 1 February 2023 at 9:45am
CEO Investor Presentation 30 January 2023 at 1:20pm
Quarterly Activities/Appendix 4C Cash Flow Report 30 January 2023 at 9:15am
Notification regarding unquoted securities - EBR 23 December 2022 at 9:25am
Notification of cessation of securities - EBR 22 December 2022 at 11:00am
EBR shareholder letter and Australian roadshow 21 December 2022 at 9:15am
Notification of cessation of securities - EBR 20 December 2022 at 2:30pm
Application for quotation of securities - EBR 22 November 2022 at 5:35pm
Application for quotation of securities - EBR 21 November 2022 at 9:05am
Notice under ASX Listing Rule 3.10A 15 November 2022 at 12:10pm
Notification of Change in Auditor 11 November 2022 at 12:20pm
Notice under ASX Listing Rule 3.10A 11 November 2022 at 8:45am
Quarterly Activities/Appendix 4C Cash Flow Report 26 October 2022 at 9:50am
Reinstatement to Official Quotation 21 October 2022 at 9:35am
Shareholder and Investor Webinar Presentation 21 October 2022 at 9:35am
Register to track EBR and receive email alerts.